Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis
Clinical trial NCT00823693 · COMPLETED
Trial details
- NCT number
- NCT00823693
- Sponsor
- Revotar Biopharmaceuticals AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.